Prospective Electroencephalography Evaluation of Sedation in COVID-19
NCT ID: NCT04815109
Last Updated: 2022-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2021-04-01
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EEG in Resuscitated In-hospital Patients
NCT02349087
Electroencephalogram (EEG) in General Anaesthesia - More Than Only a Bispectral Index (BIS)
NCT04105660
Comparison Between High-density Electroencephalography and Conventional Electroencephalography for Comatose Patients
NCT02588482
Optimizing the Evaluation of Awareness in Disorders of Consciousness
NCT02628639
EEG Monitoring for Refractory Status Epilepticus
NCT04170491
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of our study is to collect unrelated processed and raw EEG data of sedated COVID-19 patients and to investigate the correlation to the necessary sedation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
critical ill COVID-19
Critically ill COVID-19 patients with need for ventilation and appropriate sedation
Encephalography measurement
Encephalography measurement and partially aggravated sedation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Encephalography measurement
Encephalography measurement and partially aggravated sedation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Goethe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Armin N. Flinspach
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Armin N Flinspach, M.D.
Role: PRINCIPAL_INVESTIGATOR
Goethe-University Frankfurt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Frankfurt
Frankfurt am Main, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EEG in COVID-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.